Celyad Oncology

$6.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.16 (-2.30%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CYAD and other stocks, options, and ETFs commission-free!

About CYAD

Celyad Oncology SA American Depositary Shares, also called Celyad Oncology, is a clinical-stage biotechnology company, which focuses on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. It operates through the following segments: Cardiology and Immuno-Oncology.

CEO
Filippo Joseph Petti
Employees
92
Headquarters
Mont-Saint-Guibert, Walloon Region
Founded
2007
Market Cap
102.98M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
26.20K
High Today
$7.05
Low Today
$6.65
Open Price
$7.05
Volume
29.13K
52 Week High
$13.01
52 Week Low
$6.57

CYAD Earnings

Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available Aug 4

You May Also Like

LSLT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure